THELMA Therapeutics Valuation

Is A015540 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A015540 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate A015540's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate A015540's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A015540?

Key metric: As A015540 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for A015540. This is calculated by dividing A015540's market cap by their current revenue.
What is A015540's PS Ratio?
PS Ratio	0.7x
Sales	₩6.51b
Market Cap	₩4.37b

A015540 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does A015540's PS Ratio compare to its peers?

The above table shows the PS ratio for A015540 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.1x
A169330 Macromill Embrain	0.7x	n/a	₩36.2b
A273060 Wise birds	2x	n/a	₩41.3b
A123570 eMnet	1.4x	n/a	₩52.1b
A214270 FSN	0.3x	n/a	₩62.3b
A015540 THELMA Therapeutics	0.7x	n/a	₩4.4b

Price-To-Sales vs Peers: A015540 is good value based on its Price-To-Sales Ratio (0.7x) compared to the peer average (1x).

Price to Sales Ratio vs Industry

How does A015540's PS Ratio compare vs other companies in the KR Media Industry?

1 Company	Price / Sales	Estimated Growth	Market Cap
A037560 LG HelloVision	0.2x	1.1%	US$136.75m

No more companies available in this PS range

1 Company		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: A015540 is good value based on its Price-To-Sales Ratio (0.7x) compared to the KR Media industry average (1.4x).

Price to Sales Ratio vs Fair Ratio

What is A015540's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A015540 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.7x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate A015540's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Nasmedia

₩161.5b

Operates as a digital marketing platform company in South Korea.

A089600

₩14,280.00

2.4%

-30.3%

Innocean Worldwide

₩798.4b

Provides marketing and communications services in the Americas, Europe, Asia, Oceania, the Middle East, and internationally.

A214320

₩19,960.00

-4.8%

JOYCITY

₩98.4b

Operates as a gaming company worldwide.

A067000

₩1,408.00

2.6%

-48.8%